KFx Medical Awarded Key Patent for Knotless Tissue Fixation and Double Row Rotator Cuff Surgery

Patent No. 7,585,311 awarded by the United States Patent and Trademark office
for knotless surgery tissue fixation
SAN DIEGO--(Business Wire)--
KFx Medical Corporation announced today that on September 8, 2009, it was
awarded U.S. Patent No. 7,585,311 by the United States Patent and Trademark
office.The key patent covers a broad range of methods used to perform surgical
knotless tissue fixation, including the double row tissue repair technique used
to restore the rotator cuff to its correct anatomic position.

"This broad seminal patent is an important milestone for our company and was the
result of a great team effort over many years by KFx and our patent counsel,
Knobbe, Martens, Olson, & Bear," indicated Tate Scott, President and CEO."Double
row repairs restore the correct anatomy and have been demonstrated to result in
better clinical outcomes with fewer re-tears of the rotator cuff."

Double row techniques have proven difficult for a number of sports medicine and
orthopedic surgeons to perform due to the multitude of knots that must be tied
through canuulas and under arthroscopic viewing.KFx`s products are designed to
eliminate knot tying and reduce the overall surgical time and effort needed for
this surgical approach.

About KFx Medical Corporation

Headquartered in Carlsbad, Calif., KFx Medical Corporation was founded in 2003
to develop clinically relevant solutions to rotator cuff repair. Over four
million people seek medical advice for shoulder pain every year; torn rotator
cuffs alone account for more than 500,000 surgeries annually, requiring many
months of rehabilitation. Traditional minimally invasive techniques, although
promising (patients typically experience less pain and regain full range of
motion more quickly) require surgeons to have advanced arthroscopy skills. In
contrast, KFx provides simple systems for surgeons while ensuring a more
anatomical repair for the patient, yielding better clinical outcomes.Investors
include: Alloy Ventures, Arboretum Ventures, Charter Life Sciences, Montreux
Equity Partners and MB Venture Partners.

KFx Medical Corporation
Tate Scott
President and CEO
Tate.Scott@kfxmed.com
760-444-8820

Copyright Business Wire 2009